Danaher Corp (DHR) 98.21 $DHR Danaher Set to Possibly

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Danaher Corp (DHR) 98.21 $DHR

Danaher Set to Possibly Rebound After Yesterday's Selloff of 1.42%
Comtex SmarTrend(R) - Fri Jun 24, 3:09PM CDT
Danaher (NYSEHR) traded in a range yesterday that spanned from a low of $97.65 to a high of $100.01. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $98.71 on volume of 3.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
DHR: 98.21 (-2.23)

Albemarle and Fortive Set to Join the S&P 500; EMCOR to Join S&P MidCap 400; Inteliquent to Join S&P SmallCap 600
PR Newswire - Thu Jun 23, 4:46PM CDT
S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices:
SPGI: 104.14 (-6.48), TE: 27.66 (-0.01), IQNT: 18.61 (+0.77), EMA.TO: 47.41 (+0.93), ALB: 78.98 (-5.42), TRP.TO: 57.28 (-0.06), DHR: 98.21 (-2.23), CPGX: 25.47 (-0.01), EME: 47.63 (-1.73)

Fortive Announces Equity Investor Meetings For Upcoming Spin-off From Danaher And Provides Financial Outlook As Standalone Company
PR Newswire - Tue Jun 21, 5:00AM CDT
Fortive Corporation ("Fortive" (NYSE: FTV.WI) announced today that it will begin making presentations to the equity investment community in preparation for its planned July 2, 2016 spin-off from Danaher Corporation (NYSE: DHR) ("Danaher", including a webcast presentation today at approximately 12:30 p.m. ET. The meetings will be led by President and Chief Executive Officer, James A. Lico, and Senior Vice President and Chief Financial Officer, Charles E. McLaughlin.
DHR: 98.21 (-2.23)

Look for Shares of Danaher to Potentially Pullback after Yesterday's 1.46% Rise
Comtex SmarTrend(R) - Mon Jun 20, 3:41PM CDT
Danaher (NYSEHR) traded in a range yesterday that spanned from a low of $98.88 to a high of $99.62. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $99.26 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DHR: 98.21 (-2.23)

Fortive Prices Private Offering of Additional 4.300% Senior Notes due 2046
PR Newswire - Thu Jun 09, 3:15PM CDT
Danaher Corporation (NYSE: DHR) and Fortive Corporation announced today, in connection with the planned spin-off of Fortive from Danaher, that Fortive has priced the previously announced offering of an additional $200 million aggregate principal amount of 4.300% senior notes due 2046 (the "additional 2046 notes". On June 6, 2016, Fortive agreed to issue $350 million aggregate principal amount of 4.300% senior notes due 2046 (the "prior 2046 notes" and together with the additional 2046 notes, the "2046 notes" pursuant to a private offering. The additional 2046 notes to be issued in this offering and the previously priced prior 2046 notes will be treated as a single class of notes under the indenture governing such 2046 notes and all such 2046 notes are expected to be issued on June 20, 2016, subject to customary closing conditions. The additional 2046 notes will be fungible with the prior 2046 notes. Danaher will guarantee the 2046 notes until the spin-off occurs. The 2046 notes will pay interest on a semi-annual basis. Fortive intends to use the net proceeds from the sale of the additional 2046 notes to make payments to Danaher as consideration for the contribution of assets to Fortive by Danaher in connection with the separation, and to pay related fees and expenses and for general corporate purposes. Fortive expects that the net proceeds of the additional 2046 notes will reduce incrementally other types of indebtedness Fortive had anticipated incurring to fund such payments.
DHR: 98.21 (-2.23)

Fortive Announces Private Offering of Additional 4.300% Senior Notes due 2046
PR Newswire - Thu Jun 09, 9:25AM CDT
Danaher Corporation (NYSE: DHR) and Fortive Corporation announced today, in connection with the planned spin-off of Fortive from Danaher, that Fortive intends to offer up to an additional $200 million aggregate principal amount of 4.300% senior notes due 2046 (the "additional 2046 notes", subject to market conditions and other factors. On June 6, 2016, Fortive agreed to issue $350 million aggregate principal amount of 4.300% senior notes due 2046 (the "prior 2046 notes" and together with the additional 2046 Notes, the "2046 notes" pursuant to a private offering. The additional 2046 notes to be issued in this offering and the previously priced prior 2046 notes will be treated as a single class of notes under the indenture governing such 2046 notes and all such 2046 notes are expected to be issued on June 20, 2016, subject to customary closing conditions. The additional 2046 notes are expected to be fungible with the prior 2046 notes. Danaher will guarantee the 2046 notes until the spin-off occurs. Fortive intends to use the net proceeds from the sale of the additional 2046 notes to make payments to Danaher as consideration for the contribution of assets to Fortive by Danaher in connection with the separation, and to pay related fees and expenses and for general corporate purposes. Fortive expects that the net proceeds of the additional 2046 notes will reduce incrementally other types of indebtedness Fortive had anticipated incurring to fund such payments.
DHR: 98.21 (-2.23)

Fortive Prices Private Offering of Senior Notes
PR Newswire - Mon Jun 06, 5:32PM CDT
Danaher Corporation (NYSE: DHR) and Fortive Corporation announced today, in connection with the planned spin-off of Fortive from Danaher, that Fortive has priced the previously announced offering of $300 million of 1.800% senior notes due 2019, $750 million of 2.350% senior notes due 2021, $900 million of 3.150% senior notes due 2026 and $350 million of 4.300% senior notes due 2046. The closing of the offering is expected to occur on June 20, 2016, subject to customary closing conditions. Danaher will guarantee the notes until the spin-off occurs. The notes will pay interest on a semi-annual basis. Fortive intends to use the net proceeds from the sale of the notes to make payments to Danaher as consideration for the contribution of assets to Fortive by Danaher in connection with the separation, and to pay related fees and expenses and for general corporate purposes.
DHR: 98.21 (-2.23)

Fortive Announces Private Offering of Senior Notes
PR Newswire - Mon Jun 06, 8:06AM CDT
Danaher Corporation (NYSE: DHR) and Fortive Corporation announced today, in connection with the planned spin-off of Fortive from Danaher, that Fortive intends to offer senior notes, subject to market conditions and other factors. Danaher will guarantee the notes until the spin-off occurs. Fortive intends to use the net proceeds from the sale of the notes to make payments to Danaher as consideration for the contribution of assets to Fortive by Danaher in connection with the separation, and to pay related fees and expenses and for general corporate purposes.
DHR: 98.21 (-2.23)

Danaher To Present At Goldman Sachs Global Healthcare Conference
PR Newswire - Thu Jun 02, 3:15PM CDT
Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr. will be presenting at the Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, California on Thursday, June 9 at 8:00 a.m. PT. The audio will be simultaneously webcast and the presentation will be archived on www.danaher.com.
DHR: 98.21 (-2.23)

Global Medical Equipment Market Analytics Report 2016-2020 - Analysis, Technologies & Forecasts - Key Vendors: Medtronic, Johnson & Johnson, Danaher - Research and Markets
BusinessWire - Thu Jun 02, 6:16AM CDT
Research and Markets has announced the addition of the "Medical Equipment Global Market Analytics Report 2016" report to their offering.
JNJ: 115.63 (-1.75), MDT: 83.26 (-2.51), DHR: 98.21 (-2.23)

Danaher Declares Pro Rata Dividend Of Fortive Common Stock And Announces Expected "When-Issued" Trading Of Fortive Common Stock
PR Newswire - Wed Jun 01, 3:15PM CDT
Danaher Corporation (NYSE: DHR) today announced that the Danaher Board of Directors has declared a pro rata dividend of all of the common stock of Fortive Corporation to Danaher stockholders of record as of the close of business on June 15, 2016 (the "Record Date". The dividend is payable on July 2, 2016 ("Distribution Date" in connection with the previously announced separation of Danaher's existing Test & Measurement segment, Industrial Technologies segment (excluding the Product Identification platform) and Retail/Commercial Petroleum platform through the planned spin-off of Fortive. As a result of the dividend, Danaher stockholders will receive one share of Fortive common stock for every two shares of Danaher common stock they hold on the Record Date.
DHR: 98.21 (-2.23)

WallStreet Research(TM) Announces Availability of Updated Corporate Profile Coverage On Pressure BioSciences, Inc. (OTCQB: PBIO)
ACCESSWIRE - Tue May 31, 9:01PM CDT
NEW YORK, NY / ACCESSWIRE / May 31, 2016 / WallStreet Research™, a top-ranked independent research firm with a history spanning over three decades, today announced that the firm has updated corporate profile coverage on Pressure BioSciences, Inc. (OTCQB: PBIO). WallStreet Research™ is ranked number one on the Google, Yahoo, and Bing search engines in both and small and microcap research. An updated analyst Corporate Profile Report, together with additional information about WallStreet Research™, is available at the www.WallStreetResearch.org website.
DHR: 98.21 (-2.23)

SeeThruEquity Issues Update on Pressure BioSciences (OTCQB: PBIO), Raises Price Target to $1.75
ACCESSWIRE - Thu May 26, 8:00AM CDT
NEW YORK, NY / ACCESSWIRE / May 26, 2016 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has issued an update on Pressure BioSciences, Inc. (OTCQB: PBIO).
DHR: 98.21 (-2.23)

Danaher To Present At Bernstein Strategic Decisions Conference
PR Newswire - Wed May 25, 5:00PM CDT
Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr. will be presenting at the Bernstein Strategic Decisions Conference in New York City on Thursday, June 2 at 9:00 a.m. ET. The audio will be simultaneously webcast and the presentation will be archived on www.danaher.com.
DHR: 98.21 (-2.23)

Danaher Set to Possibly Pullback After Yesterday's Rally of 1.30%
Comtex SmarTrend(R) - Tue May 24, 2:57PM CDT
Danaher (NYSEHR) traded in a range yesterday that spanned from a low of $98.70 to a high of $100.20. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $99.40 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DHR: 98.21 (-2.23)

Fortive Form 10 Registration Statement Declared Effective
PR Newswire - Fri May 20, 4:55PM CDT
Today, Danaher Corporation (NYSE: DHR) ("Danaher" announced that the U.S. Securities and Exchange Commission has declared effective the Registration Statement on Form 10 of Fortive Corporation ("Fortive". The Registration Statement on Form 10 includes information regarding Fortive's business and the spin-off of Fortive from Danaher, which is expected to be completed on July 2, 2016. In addition, on May 12, 2016, the New York Stock Exchange authorized Fortive for listing on the exchange with the ticker symbol "FTV."
DHR: 98.21 (-2.23)

How Investors Feel About the Diversified Machinery Industry? - General Electric, Honeywell Intl., Eaton and Danaher
PR Newswire - Fri May 20, 7:05AM CDT
At ActiveWallSt.com today, we direct our focus on four equities in the Diversified Machinery space: General Electric Co. (NYSE: GE), Honeywell International Inc. (NYSE: HON), Eaton Corp. PLC (NYSE: ETN), and Danaher Corp. (NYSE: DHR). Find out how you can trade these names to your advantage by registering at:
GE: 29.82 (-1.37), ETN: 58.03 (-4.79), HON: 112.98 (-4.34), DHR: 98.21 (-2.23)

Danaher And Fortive To Webcast Investor And Analyst Event
PR Newswire - Thu May 19, 4:00PM CDT
Danaher Corporation (NYSEHR) ("Danaher" and Fortive Corporation ("Fortive" invite you to listen to a live webcast presentation of our investor and analyst event on Thursday, May 26, 2016. The webcast will begin at approximately 12:00 p.m. ET and conclude at approximately 2:30 p.m. ET. The event, to be hosted at our Gilbarco Veeder-Root facility in Greensboro, North Carolina, will include an overview of Fortive and a comprehensive look at our Gilbarco Veeder-Root businesses. A link to the webcast and accompanying slide presentation will be available and archived on the "Investors" sections of www.danaher.com and www.fortive.com under "Events & Presentations."
DHR: 98.21 (-2.23)

After Yesterday's Decline of 1.08%, Danaher Offers Investors Better Value
Comtex SmarTrend(R) - Thu May 19, 1:28PM CDT
Danaher (NYSEHR) traded in a range yesterday that spanned from a low of $97.03 to a high of $97.93. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $97.28 on volume of 1.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
DHR: 98.21 (-2.23)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 0

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 206

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 0

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 64

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 50

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 208

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 79

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 287

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 7

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 124

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading

Top 5 Most Recently Viewed Articles

Red Cat Holdings Faces Class Action Lawsuit from Investors

Updated Category News Views 209

Overview of the Class Action Against Red Cat Holdings Pomerantz LLP has announced that a class action lawsuit has been initiated against Red Cat Holdings, Inc. (RCAT) and certain officers due to allegations of misconduct. The legal action is filed in the United States District Court for the District of New Jersey. This lawsuit represents a class of individuals or entities...

Continue Reading
IPVanish: The Ultimate Solution for Cloud Storage Security

Updated Category News Views 129

IPVanish: Leading the Charge in Cloud Security As more individuals and businesses migrate to the cloud, the urgency for secure storage solutions has skyrocketed. IPVanish has stepped up to become a standout player in this landscape, recognized for its outstanding cloud access tools and strong privacy measures. Transformation into a Comprehensive Security Platform...

Continue Reading
Runway Growth Capital Bolsters Leadership with Rovner

Updated Category News Views 11

A New Era for Runway Growth Capital Alright folks, here's the scoop for anyone tracking the moves in the growth lending space: Michael Rovner, with his hefty 30-year career in the financial sector, is now taking on the role of Co-Chief Executive Officer and Co-Chief Investment Officer at Runway Growth Capital. This guy's a veteran, no doubt, having navigated the overlaps...

Continue Reading
Investors Anticipate Earnings from Booz Allen Hamilton Soon

Updated Category News Views 134

Market Expectations for Booz Allen Hamilton's Earnings Booz Allen Hamilton (NYSE: BAH) is set to unveil its quarterly earnings soon, and it's important for investors to be well-prepared. Analysts anticipate an earnings per share (EPS) of $1.51, a key figure to watch as it could impact stock sentiment significantly. Performance Insights and Analyst Predictions The hope...

Continue Reading
USD/JPY Holds Steady Amid Economic Shifts and Data Releases

Updated Category News Views 124

USD/JPY Stabilizes After Inflation Adjustments The USD/JPY currency pair has recently stabilized after a brief drop below the key level of 141.77. This dip happened just before the US Consumer Price Index (CPI) was announced, revealing an inflation rate of 2.5%. Following this data release, the currency pair started to rebound, thanks in part to a slight increase in US...

Continue Reading